Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 4/4/2020
SIETES contiene 92956 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Lineberry N, Berlin JA, Mansi B, Glasser S, Berkwits M, Klem C, Bhattacharya A, Citrome L, Enck R, Fletcher J, Haller D, Chen T-T, Laine C. Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective. BMJ 2016;354:i5078. [Ref.ID 100797]
2. Cita con resumen
Chan A-W, Telzlaff JM, Altman DG, Laupacis A, Gotzche PC, Krieza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200-7. [Ref.ID 94901]
3. Cita con resumen
Kimmel SE, Schelleman H, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD. The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol 2011;72:514-7. [Ref.ID 90997]
4.
Ilkhanoff L, Lewis JD, Hennessy S, Berlin JA, Kimmel SE. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction. Pharmacoepidemiol Drug Saf 2005;14:513-22. [Ref.ID 74563]
6.Tiene citas relacionadas Cita con resumen
Kimmel PL, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL. Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med 2005;142:157-64. [Ref.ID 72722]
7. Cita con resumen
Kimmel PL, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Strom BL. Nonfatal myocardial infarction risk among users of aspirin and nonselective non-aspirin nonsteroidal anti-inflammatory medications. Pharmacoepidemiol Drug Saf 2003;12:S72. [Ref.ID 67119]
8.Tiene citas relacionadas
Halpern SD, Karlawish JHT, Berlin JA. The ethics of underpowered clinical trials. In reply. JAMA 2002;288:2119. [Ref.ID 63961]
9.Tiene citas relacionadas Cita con resumen
Halpern SD, Karlawish JHT, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA 2002;288:358-62. [Ref.ID 62796]
10. Cita con resumen
Kimmel PL, Berlin JA, Kinman JL, Hennessy S, Feldman H, Carson JL, Strom BL. Parenteral ketorolac and risk of myocardial infarction. Pharmacoepidemiol Drug Saf 2002;11:113-9. [Ref.ID 61661]
11. Cita con resumen
Moher D, Pham B, Klassen TP, Schulz KF, Berlin JA, Jadad AR, Liberati A. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol 2000;53:964-72. [Ref.ID 52634]
12.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000;283:2008-12. [Ref.ID 50538]
13.
Bilker WB, Berlin JA, Gail MH, Strom BL. An efficient design for verifying disease outcome status in large cohorts with rare exposures and low disease rates. Stat Med 1999;18:3021-36. [Ref.ID 47815]
14.Tiene citas relacionadas
Berlin JA, Rennie D. Measuring the quality of trials. The quality of quality scales. JAMA 1999;282:1083-5. [Ref.ID 46827]
15.Tiene citas relacionadas Cita con resumen
Berlin JA, Colditz GA. The role of meta-analysis in the regulatory process for foods, drugs, and devices. JAMA 1999;281:830-4. [Ref.ID 44736]
16. Cita con resumen
Strom BL, Schinnar R, Gibson GA, Brennan PJ, Berlin JA. Risk of bleeding and hypoprothrombinemia associated with NMTT side chain antibiotics: using cefoperazone as a test case. Pharmacoepidemiol Drug Saf 1999;8:81-94. [Ref.ID 44314]
17.
Hennessy S, Bilker WB, Berlin JA, Strom BL. Factors influencing the optimal control-to-case ratio in matched case-control studies. Am J Epidemiol 1999;149:195-7. [Ref.ID 43256]
18.Tiene citas relacionadas Cita con resumen
Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM, Kaye D. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med 1998;129:761-9. [Ref.ID 41657]
19.
Cho MK, Justice AC, Winker MA, Berlin JA, Waeckerle JF, Callaham ML, Rennie D, and the PEER Investigators. Masking author identity in peer review. What factors influence masking success?. JAMA 1998;280:243-5. [Ref.ID 39392]
20.
Justice AC, Cho MK, Winker MA, Berlin JA, Rennie D, and the PEER Investigators. Does masking author identity improve peer review quality? A randomized controlled trial. JAMA 1998;280:240-2. [Ref.ID 39391]
Seleccionar todas
 
 1 a 20 de 32 siguiente >>